Tian, T., Yu, M., Li, J., Jiang, M., Ma, D., Tang, S., . . . Lu, Y. (2021). Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Tian, Tian, et al. Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Tian, Tian, et al. Front-Line ICI-Based Combination Therapy Post-TKI Resistance May Improve Survival in NSCLC Patients With EGFR Mutation. Frontiers Media S.A, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.